Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.08B | 6.12B | 6.26B | 6.04B | 5.81B | 4.92B |
Gross Profit | 2.32B | 2.32B | 2.35B | 2.43B | 2.43B | 2.11B |
EBITDA | 251.93M | 7.05M | -971.83M | 407.75M | 452.22M | 352.36M |
Net Income | -66.99M | -101.82M | -1.28B | 90.80M | 164.42M | -26.48M |
Balance Sheet | ||||||
Total Assets | 5.12B | 5.19B | 5.36B | 6.61B | 6.50B | 6.08B |
Cash, Cash Equivalents and Short-Term Investments | 133.34M | 165.76M | 125.43M | 201.90M | 211.60M | 111.40M |
Total Debt | 2.92B | 2.94B | 3.04B | 3.13B | 3.05B | 3.00B |
Total Liabilities | 4.01B | 4.08B | 4.18B | 4.23B | 4.24B | 4.02B |
Stockholders Equity | 1.11B | 1.11B | 1.18B | 2.38B | 2.27B | 2.07B |
Cash Flow | ||||||
Free Cash Flow | 46.87M | 49.68M | -9.88M | 67.98M | 119.11M | 109.06M |
Operating Cash Flow | 170.63M | 177.67M | 215.72M | 346.00M | 358.21M | 268.62M |
Investing Cash Flow | -119.29M | -123.90M | -207.44M | -320.32M | -237.08M | -157.19M |
Financing Cash Flow | -3.46M | -8.75M | -85.35M | -33.84M | -18.78M | -146.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $17.14B | 46.25 | 76.24% | ― | 7.64% | 369.79% | |
77 Outperform | $35.20B | 18.25 | 36.48% | 1.53% | 2.04% | -15.61% | |
71 Outperform | $15.13B | 17.50 | 30.21% | 5.31% | -3.23% | -28.11% | |
67 Neutral | $17.68B | 20.93 | 19.19% | 3.23% | 1.99% | -32.18% | |
56 Neutral | $3.37B | 4.05 | -1.30% | 6.64% | 0.16% | -63.79% | |
54 Neutral | $10.55B | 51.15 | 6.62% | ― | -25.30% | 479.26% | |
47 Neutral | $859.28M | ― | -5.90% | ― | -2.37% | 95.07% |
On June 5, 2025, Petco Health and Wellness Company reported its financial results for the first quarter of 2025, revealing a 2.3% decrease in net sales to $1.5 billion compared to the previous year, yet achieving an improved operating income of $16.4 million. Despite a slight decline in comparable sales, the company expanded its gross profit margin and improved its GAAP net loss, while reaffirming its fiscal 2025 net sales and earnings outlook. Petco’s CEO highlighted the company’s strategic focus on strengthening retail fundamentals and achieving sustainable growth, with the current market conditions accelerating these efforts.
The most recent analyst rating on (WOOF) stock is a Hold with a $3.25 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.
On May 19, 2025, Christy Lake resigned from Petco Health and Wellness Company‘s Board of Directors and its compensation committee, effective after the 2025 Annual Meeting of Stockholders. Her resignation was not due to any disagreement with the company. Following her resignation, the Board decided to reduce its size to 10 directors.
The most recent analyst rating on (WOOF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.